Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01143688 · ClinicalTrials.gov registry record · NA
Characterization of Placebo Responses in Stable Asthma
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT01143688 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 39 participants.
The verdict
NCT01143688, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The investigators hypothesize that different placebos will have different effects on subjective and objective asthma outcomes compared with actual therapy and natural history. . Subjects with asthma are randomly treated with placebo inhaler, placebo acupuncture, albuterol inhaler, or "no treatment" in random order, on three different occasions each. At each of the 12 visits, spirometry is performed repeatedly over 2 hours. Maximum FEV1 achieved and an 11-point, self-reported scale of improvement are examined.
Interventions
- DRUG albuterol
- DRUG placebo inhaler
- PROCEDURE placebo acupuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2005-01 |
| Est. Completion | 2009-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01143688
The ClinicalTrials.gov registry entry for NCT01143688 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which albuterol is the first listed.
NCT01143688 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01143688 about?
NCT01143688 is a clinical study titled "Characterization of Placebo Responses in Stable Asthma". The investigators hypothesize that different placebos will have different effects on subjective and objective asthma outcomes compared with actual therapy and natural history. . Subjects with asthma are randomly treated with placebo inhaler, placebo acupuncture, albuterol inhaler, or "no treatment"...
What is the current status of trial NCT01143688?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2005-01. Estimated completion is 2009-01.
What interventions are being tested in trial NCT01143688?
The interventions under investigation include: albuterol (DRUG), placebo inhaler (DRUG), placebo acupuncture (PROCEDURE).
Who is sponsoring clinical trial NCT01143688?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.